- Home
- AEHR vs BDTX Comparison
AEHR vs BDTX Comparison
Compare AEHR & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEHR | BDTX |
|---|---|---|
| Founded | 1977 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 716.3M | 148.1M |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AEHR | BDTX |
|---|---|---|
| Price | $22.18 | $2.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.60 |
| AVG Volume (30 Days) | 538.3K | ★ 1.6M |
| Earning Date | 01-08-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | $56,818,000.00 | ★ $70,000,000.00 |
| Revenue This Year | $2.55 | N/A |
| Revenue Next Year | $34.99 | N/A |
| P/E Ratio | ★ N/A | $6.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.27 | $1.20 |
| 52 Week High | $34.35 | $4.94 |
Technical Indicators
Market Signals| Indicator | AEHR | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.81 | 33.50 |
| Support Level | $19.90 | $2.52 |
| Resistance Level | $23.20 | $2.69 |
| Average True Range (ATR) | 1.28 | 0.12 |
| MACD | -0.16 | 0.03 |
| Stochastic Oscillator | 36.19 | 17.44 |
Price Performance
Historical ComparisonAbout AEHR Aehr Test Systems
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.